Overview

Bioequivalence And Lack Of Food Effects Of 300mg Lamotrigine XR

Status:
Completed
Trial end date:
2007-04-27
Target enrollment:
Participant gender:
Summary
This study intends to demonstrate bioequivalence and lack of food effect on 300mg lamotrigine XR in healthy male and female volunteers
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Anticonvulsants
Lamotrigine